These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36457141)

  • 41. Diagnostic Accuracy of Natriuretic Peptides for Heart Failure in Patients with Pleural Effusion: A Systematic Review and Updated Meta-Analysis.
    Han ZJ; Wu XD; Cheng JJ; Zhao SD; Gao MZ; Huang HY; Gu B; Ma P; Chen Y; Wang JH; Yang CJ; Yan ZH
    PLoS One; 2015; 10(8):e0134376. PubMed ID: 26244664
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A multimarker approach to diagnose and stratify heart failure.
    Wan Y; Xhang X; Atherton JJ; Kostner K; Dimeski G; Punyadeera C
    Int J Cardiol; 2015 Feb; 181():369-75. PubMed ID: 25555282
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of predictive value of NT-proBNP, sST2 and MMPs in heart failure patients with different ejection fractions.
    Pan W; Yang D; Yu P; Yu H
    BMC Cardiovasc Disord; 2020 Apr; 20(1):208. PubMed ID: 32354356
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of increased body mass index on accuracy of B-type natriuretic peptide (BNP) and N-terminal proBNP for diagnosis of decompensated heart failure and prediction of all-cause mortality.
    Christenson RH; Azzazy HM; Duh SH; Maynard S; Seliger SL; Defilippi CR
    Clin Chem; 2010 Apr; 56(4):633-41. PubMed ID: 20167699
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combining the use of amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the prognosis of hospitalized heart failure patients.
    Wang Y; Zhang R; Huang Y; Zhai M; Zhou Q; An T; Huang Y; Zhao X; Tian P; Zhang Y; Zhang J
    Clin Chim Acta; 2019 Apr; 491():8-14. PubMed ID: 30594544
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Usefulness of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide as biomarkers for heart failure in young children with single ventricle congenital heart disease.
    Lowenthal A; Camacho BV; Lowenthal S; Natal-Hernandez L; Liszewski W; Hills NK; Fineman JR; Bernstein HS
    Am J Cardiol; 2012 Mar; 109(6):866-72. PubMed ID: 22196786
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combination of quantitative capnometry, N-terminal pro-brain natriuretic peptide, and clinical assessment in differentiating acute heart failure from pulmonary disease as cause of acute dyspnea in pre-hospital emergency setting: study of diagnostic accuracy.
    Klemen P; Golub M; Grmec S
    Croat Med J; 2009 Apr; 50(2):133-42. PubMed ID: 19399946
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Midregional pro-A-type natriuretic peptide measurements for diagnosis of acute destabilized heart failure in short-of-breath patients: comparison with B-type natriuretic peptide (BNP) and amino-terminal proBNP.
    Gegenhuber A; Struck J; Poelz W; Pacher R; Morgenthaler NG; Bergmann A; Haltmayer M; Mueller T
    Clin Chem; 2006 May; 52(5):827-31. PubMed ID: 16543387
    [TBL] [Abstract][Full Text] [Related]  

  • 49. N-Terminal Pro-Brain Natriuretic Peptide and Heart Failure Risk Among Individuals With and Without Obesity: The Atherosclerosis Risk in Communities (ARIC) Study.
    Ndumele CE; Matsushita K; Sang Y; Lazo M; Agarwal SK; Nambi V; Deswal A; Blumenthal RS; Ballantyne CM; Coresh J; Selvin E
    Circulation; 2016 Feb; 133(7):631-8. PubMed ID: 26746175
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New issues on measurement of B-type natriuretic peptides.
    Clerico A; Zaninotto M; Passino C; Plebani M
    Clin Chem Lab Med; 2017 Nov; 56(1):32-39. PubMed ID: 28809748
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of BNP and NT-proBNP assays in the approach to the emergency diagnosis of acute dyspnea.
    Sanz MP; Borque L; Rus A; Vicente B; Ramírez Y; Lasa L
    J Clin Lab Anal; 2006; 20(6):227-32. PubMed ID: 17115420
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
    Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
    Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Soluble neprilysin, NT-proBNP, and growth differentiation factor-15 as biomarkers for heart failure in dialysis patients (SONGBIRD).
    Claus R; Berliner D; Bavendiek U; Vodovar N; Lichtinghagen R; David S; Patecki M; Launay JM; Bauersachs J; Haller H; Hiss M; Balzer MS
    Clin Res Cardiol; 2020 Aug; 109(8):1035-1047. PubMed ID: 32002632
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of glycosylation on plasma N-terminal proBNP-76 levels in patients with heart or renal failure.
    Nishikimi T; Ikeda M; Takeda Y; Ishimitsu T; Shibasaki I; Fukuda H; Kinoshita H; Nakagawa Y; Kuwahara K; Nakao K
    Heart; 2012 Jan; 98(2):152-61. PubMed ID: 21719557
    [TBL] [Abstract][Full Text] [Related]  

  • 55. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study.
    Januzzi JL; van Kimmenade R; Lainchbury J; Bayes-Genis A; Ordonez-Llanos J; Santalo-Bel M; Pinto YM; Richards M
    Eur Heart J; 2006 Feb; 27(3):330-7. PubMed ID: 16293638
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biomarkers for characterization of heart failure - Distinction of heart failure with preserved and reduced ejection fraction.
    Sinning C; Kempf T; Schwarzl M; Lanfermann S; Ojeda F; Schnabel RB; Zengin E; Wild PS; Lackner KJ; Munzel T; Blankenberg S; Wollert KC; Zeller T; Westermann D
    Int J Cardiol; 2017 Jan; 227():272-277. PubMed ID: 27838133
    [TBL] [Abstract][Full Text] [Related]  

  • 57. N-terminal pro-brain natriuretic peptide and exercise capacity in chronic heart failure: data from the Heart Failure and a Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) study.
    Felker GM; Whellan D; Kraus WE; Clare R; Zannad F; Donahue M; Adams K; McKelvie R; Piña IL; O'Connor CM;
    Am Heart J; 2009 Oct; 158(4 Suppl):S37-44. PubMed ID: 19782787
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms.
    Januzzi JL; Chen-Tournoux AA; Moe G
    Am J Cardiol; 2008 Feb; 101(3A):29-38. PubMed ID: 18243855
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure.
    Bruins S; Fokkema MR; Römer JW; Dejongste MJ; van der Dijs FP; van den Ouweland JM; Muskiet FA
    Clin Chem; 2004 Nov; 50(11):2052-8. PubMed ID: 15345664
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The diagnostic utility of N-terminal pro-B-type natriuretic peptide for the detection of major structural heart disease in patients with atrial fibrillation.
    Shelton RJ; Clark AL; Goode K; Rigby AS; Cleland JG
    Eur Heart J; 2006 Oct; 27(19):2353-61. PubMed ID: 16952921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.